Archive: 30/10/2013

Six-month data of the LEVANT 2 trial presented

The first clinical trial in the United States to study the use of drug coated balloons (DCB) for femoropopliteal artery disease found the procedure is promising for safety and efficacy at six months. Six month data of the ...

page 4 from 11